CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 13351-13352 [2017-04742]

Download as PDF 13351 Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. INSTITUTIONS IN LIQUIDATION [In alphabetical order] FDIC ref. No. Bank name City 10525 ................ Proficio Bank ........................................................ Cottonwood Heights ............................................. OMB No.: 0970–0157. Description: 42 U.S.C. 612 (Section 412 of the Social Security Act) requires each Indian Tribe that elects to administer and operate a TANF program to submit a TANF Tribal Plan. The TANF Tribal Plan is a mandatory statement submitted to the Secretary by the Indian Tribe, which consists of an outline of how the Indian Tribes TANF program will be administered and operated. It is used by the Secretary to determine whether the plan is [FR Doc. 2017–04730 Filed 3–9–17; 8:45 am] BILLING CODE 6714–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Guidance for Tribal TANF. State UT Date closed 3/3/2017 approvable and to determine that the Indian Tribe is eligible to receive a TANF assistance grant. It is also made available to the public. Respondents: Indian Tribes applying to operate a TANF program. ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Request for State Data Needed to Determine the Amount of a Tribal Family Assistance Grant .......................................................................................... sradovich on DSK3GMQ082PROD with NOTICES Instrument 24 1 68 1,632 Estimated Total Annual Burden Hours: 1,632. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 330 C Street SW., Washington, DC 20201. Attention Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Email: OIRA_ SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration for Children and Families. Robert Sargis, Reports Clearance Officer. [FR Doc. 2017–04752 Filed 3–9–17; 8:45 am] BILLING CODE 4184–01–P VerDate Sep<11>2014 18:37 Mar 09, 2017 Jkt 241001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Health Resources and Services Administration, Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of meeting. In accordance with the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment. This meeting will be open to the public. Information about the CDC/ HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment and the meeting agenda can be obtained by contacting CDR Holly Berilla at (301) 443–9965 or hberilla@ hrsa.gov. SUMMARY: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 The meeting will be held on March 30, 2017, from 2:00 p.m. to 3:00 p.m. (Eastern). ADDRESSES: The meeting will be held virtually with telephone access that will accommodate up to 100 attendees and is open to the public. Parties may access the teleconference by dialing 888–566– 6570 and using participant code: 1682061. Participants should call and connect 15 minutes prior to the start of the meeting. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment should contact CDR Holly Berilla, Public Health Analyst, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and Data (DPD), in one of three ways: (1) Send a request to the following address: CDR Holly Berilla, Public Health Analyst, HRSA, HAB, DPD, 5600 Fishers Lane, Rockville, Maryland 20857; (2) call 301– 443–9965; or (3) send an email to hberilla@hrsa.gov. SUPPLEMENTARY INFORMATION: The CDC/ HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment was established under Section 222 of the Public Health Service DATES: E:\FR\FM\10MRN1.SGM 10MRN1 13352 Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices Act (42 U.S.C. Section 217a), as amended. The purpose of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment is to advise the Secretary of HHS, the Director of CDC, and the Administrator of HRSA regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STDs; prevention and treatment efforts including surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional eduction, patient healthcare delivery, and prevention services; HHS policies about prevention of HIV/AIDS, viral hepatitis and other STDs; treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to CDC and HRSA in their developoment of responses to emerging health needs related to HIV, viral hepatitis, and other STDs. During the March 30, 2017 meeting, the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will deliberate and vote on a proposed resolution regarding the HIV workforce, a proposal to expand the existing HCV (hepatitis C virus) Workgroup, and a proposal to develop an HIV Disparities Workgroup. Agenda items are subject to change as priorities dictate. Due to the nature and time limitations of the meeting, members of the public will not have an opportunity to provide oral comments. Individuals who need reasonable accommodations should notify CDR Holly Berilla at hberilla@ hrsa.gov at least 10 days prior to the meeting. Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2017–04742 Filed 3–9–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary [Document Identifier: 0990–0324–30D] Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, has submitted an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB) for review and approval. The ICR is for reinstatement of a previously-approved SUMMARY: information collection assigned OMB control number 0990–0324, which expired on March 31, 2011. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public on this ICR during the review and approval period. DATES: Comments on the ICR must be received on or before April 10, 2017. ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Information Collection Clearance staff, Information.CollectionClearance@ hhs.gov or (202) 690–5683. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the OMB control number 0990–0324 for reference. Information Collection Request Title: The Commissioned Corps of the U.S. Public Health Service Application— Medical Forms. Abstract: The principal purpose for collecting the information is to permit HHS to determine eligibility for appointment of applicants into the Commissioned Corps of the U.S. Public Health Service (Corps). The Corps is one of the seven Uniformed Services of the United States (37 U.S.C. 101(3)), and appointments in the Corps are made pursuant to 42 U.S.C. 204 et seq. and 42 CFR 21.58. The application consists of PHS Medical forms noted below. Likely Respondents: Candidates/ Applicants to the Commissioned Corps. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form No. Total burden hours ........................................................................................ ........................................................................................ ........................................................................................ ........................................................................................ ........................................................................................ ........................................................................................ ........................................................................................ ........................................................................................ 1,000 4,000 800 1,320 2,800 1,600 600 2,000 1 1 1 1 1 1 1 1 1 30/60 6/60 6/60 7/60 7/60 5/60 10/60 1,000 2,000 80 132 327 187 50 333 Total .......................................................................................... sradovich on DSK3GMQ082PROD with NOTICES PHS–6355 PHS–6379 PHS–7053 PHS–7054 PHS–7055 PHS–7056 PHS–7057 PHS–7061 Average burden hour per response (within 1 hour) Response per respondent ............................ ............................ ............................ 4,109 Terry S. Clark, Asst Information Collection Clearance Officer. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2017–04612 Filed 3–9–17; 8:45 am] National Committee on Vital and Health Statistics: Teleconference BILLING CODE 4150–49–P Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) VerDate Sep<11>2014 18:37 Mar 09, 2017 Jkt 241001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 announces the following advisory committee meeting to be held virtually. Name: National Committee on Vital and Health Statistics (NCVHS), Full Committee Virtual Meeting. Dates and Times: Tuesday, April 18, 2017: 3:00 p.m.–5:00 p.m. (EDT). E:\FR\FM\10MRN1.SGM 10MRN1

Agencies

[Federal Register Volume 82, Number 46 (Friday, March 10, 2017)]
[Notices]
[Pages 13351-13352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04742]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Health Resources and Services Administration, Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, notice 
is hereby given that a meeting is scheduled for the Centers for Disease 
Control and Prevention (CDC)/Health Resources and Services 
Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment. This meeting will be open to the public. 
Information about the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment and the meeting agenda can 
be obtained by contacting CDR Holly Berilla at (301) 443-9965 or 
hberilla@hrsa.gov.

DATES: The meeting will be held on March 30, 2017, from 2:00 p.m. to 
3:00 p.m. (Eastern).

ADDRESSES: The meeting will be held virtually with telephone access 
that will accommodate up to 100 attendees and is open to the public. 
Parties may access the teleconference by dialing 888-566-6570 and using 
participant code: 1682061. Participants should call and connect 15 
minutes prior to the start of the meeting.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment should contact CDR Holly Berilla, Public 
Health Analyst, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and 
Data (DPD), in one of three ways: (1) Send a request to the following 
address: CDR Holly Berilla, Public Health Analyst, HRSA, HAB, DPD, 5600 
Fishers Lane, Rockville, Maryland 20857; (2) call 301-443-9965; or (3) 
send an email to hberilla@hrsa.gov.

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service

[[Page 13352]]

Act (42 U.S.C. Section 217a), as amended.
    The purpose of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment is to advise the Secretary 
of HHS, the Director of CDC, and the Administrator of HRSA regarding 
objectives, strategies, policies, and priorities for HIV, viral 
hepatitis, and other STDs; prevention and treatment efforts including 
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, 
and related behaviors; epidemiologic, behavioral, health services, and 
laboratory research on HIV/AIDS, viral hepatitis, and other STDs; 
identification of policy issues related to HIV/viral hepatitis/STD 
professional eduction, patient healthcare delivery, and prevention 
services; HHS policies about prevention of HIV/AIDS, viral hepatitis 
and other STDs; treatment, healthcare delivery, and research and 
training; strategic issues influencing the ability of CDC and HRSA to 
fulfill their missions of providing prevention and treatment services; 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to CDC and HRSA in their developoment of 
responses to emerging health needs related to HIV, viral hepatitis, and 
other STDs.
    During the March 30, 2017 meeting, the CDC/HRSA Advisory Committee 
on HIV, Viral Hepatitis and STD Prevention and Treatment will 
deliberate and vote on a proposed resolution regarding the HIV 
workforce, a proposal to expand the existing HCV (hepatitis C virus) 
Workgroup, and a proposal to develop an HIV Disparities Workgroup. 
Agenda items are subject to change as priorities dictate.
    Due to the nature and time limitations of the meeting, members of 
the public will not have an opportunity to provide oral comments. 
Individuals who need reasonable accommodations should notify CDR Holly 
Berilla at hberilla@hrsa.gov at least 10 days prior to the meeting.

Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017-04742 Filed 3-9-17; 8:45 am]
 BILLING CODE 4165-15-P